Given the pivotal role of the IL6/JAK2/STAT3 axis in promoting tumor progression and shaping an immunosuppressive microenvironment, we performed immunohistochemical analysis of phosphorylated JAK2 and STAT3 in tumor tissues from the mouse model to validate pathway activation. The gene discussed is JAK2; the disease is neoplasm.